spacer
home > ebr > > strategy for uk life sciences
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

Industry Events

Cancer Vaccines

15-16 September 2014, Holiday Inn Regents Park, London UK

The global therapeutic cancer vaccines market is expected to grow to a value of $7.8 billion by 2019. As companies look to develop new drugs to enter this rapidly growing industry, Cancer Vaccines 2014 will mark the path forward in terms of cancer vaccine research, clinical development and regulation.
More info >>

 
News and Press Releases

Frost & Sullivan: Companion Diagnostics Benefit from Fewer Regulatory Barriers in Europe

LONDON 24th June 2014 With the growth in personalised medicine, there is an increased interest in developing companion diagnostics (CDx) tests or tests that match the right therapy to the patient. In fact, over the past few years, market participants have been entering pharmaceutical and diagnostic partnerships in a bid to develop and commercialise CDx tests for drugs that already exist in the market. Currently, the oncology segment is the focus among players in the CDx market but it is envisioned that non-oncology segments such as central nervous system, infectious disease, and cardiovascular conditions will receive immense attention in the years to come.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement